Proton Therapy System Reduces Damage to Healthy Tissue

With proton therapy, doctors can use higher doses of radiation to control and manage tumors while considerably reducing damage to healthy tissue and vital organs.

Varian Medical Systems, Inc. (Palo Alto, CA, USA) announced that it has received European CE marking for the Varian proton therapy system. "CE mark is an important milestone in Varian's initiative to develop and market a compact system capable of intensity-modulated proton therapy in single- or multi-room facilities,” commented Lester Boeh, vice president of emerging businesses for the company. "This is a clear demonstration of our ongoing commitment to provide the cancer treatment community and its patients with a clinically practical and commercially viable proton therapy system that meets accepted safety standards for medical equipment.”

The CE marking makes it possible for cancer treatment centers to begin ordering, installing, and using the Varian proton therapy system in regions where CE marking is required without having to obtain a site-specific clearance to use this important technology. "Varian is actively marketing the Varian proton therapy system, and institutions from all parts of the world are pursuing this promising technology for cancer patients in their regions,” Mr. Boeh said.

Varian has developed a comprehensive proton therapy system that utilizes the company's technology for particle beam generation, treatment planning, imaging, motion management, and information management technology.

Varian Medical Systems is a world-leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers, and medical oncology practices.

Related Links:
Varian Medical Systems